发明名称 FUSED INDANE COMPOUND
摘要 [Problems] To provide a compound which is useful as an NMDA receptor antagonist. [Means for solution] The present inventors have studied a compound having an NMDA receptor antagonistic action, and confirmed that the fused indane compound of the present invention has an excellent NMDA receptor antagonistic action, thereby completed the present invention. The fused indane compound of the present invention has an excellent NMDA receptor antagonistic action and can be used as a prophylactic and/or therapeutic agent for Alzheimer's disease, cerebrovascular dementia, Parkinson's disease, intractable depression, attention deficit hyperactivity disorder, migraines, or the like. [Selected Figure] None
申请公布号 CA2706171(C) 申请公布日期 2013.10.08
申请号 CA20082706171 申请日期 2008.11.26
申请人 ASTELLAS PHARMA INC. 发明人 HAYASHIBE, SATOSHI;YAMASAKI, SHINGO;SHIRAISHI, NOBUYUKI;HOSHII, HIROAKI;TOBE, TAKAHIKO
分类号 C07D221/16;A61K31/403;A61K31/435;A61K31/438;A61K31/538;A61K31/55;A61P25/00;C07D209/70;C07D223/32;C07D265/34;C07D491/048;C07D495/04 主分类号 C07D221/16
代理机构 代理人
主权项
地址